MTOR and head and neck squamous cell carcinoma: In this study we obtained further evidence for the anti-lymphatic properties of mTOR inhibitors employing OSC-19 orthotopic model of HNSCC and investigated the mechanisms of rapalogues anti-lymphatic effects using in vitro and in vivo models.